Why the Elixinol (ASX:EXL) share price has been halted today?

The Elixinol (ASX:EXL) share price remains in a trading halt today as the company plans a potential transaction. We take a closer look.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Elixinol Global Ltd (ASX: EXL) share price has been halted today as the company reported that it would be announcing a potential transaction.

Shares in the small-cap cannabis company have not been trading since the start of today. Consequently, the Elixinol share price remains at 19.5 cents.

ASX share price trading halt represented by serious woman putting hand up

Image source: Getty Images

What happened to Elixinol

The Elixinol share price will be one to watch in the coming days as its shares begin trading again. According to the release, the trading halt will remain in place until the announcement. Alternatively, when trading commences on March 8. Whatever is earlier.

The potential transaction is yet to be announced. Elixinol has stated that it wasn't aware of any reason why the halt should not be granted. 

Full year results

Notably, the company recently released its full-year results on February 26. Its shares have since nosedived, shedding around 9%.

Elixinol highlighted its global reset strategy. This has been put in place to stabilise its share price. For reference, the Elixinol share price has dropped an astounding 95.7% since May 2019. According to the company, the strategy has resulted in a strong balance sheet being formed. Ultimately, with lower costs and new growth catalysts. On this note, the cash at hand was $27.7 million at the time of reporting.
 
Furthermore, there was a significant margin improvement in the second half of FY2020. This comes as its business plan continues to shift more towards online and e-commerce. A sector with significant tailwinds.
 
Elixinol CEO Oliver Horn addressed the results saying:
While much of the past 12 months has been challenging for traditional retailers, we made great strides forward in our pursuit of sustainable growth and improved capital efficiency. Our strategy to reduce our cost base and shift the business towards higher margin channels, while bringing new products to market and entering new categories, is starting to show success via an improving bottom-line.
Mr. Horn also claimed the company is in a good position to benefit from the growing consumer trend for hemp wellbeing products. Despite his positive sentiment the market has struggled to make headway, falling 9% since the release.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, and holding a mobile phone in his other hand.
Broker Notes

Buy, hold, sell: CSL, QBE, and Pro Medicus shares

Let's see if analysts are bullish or bearish on these names.

Read more »

Excited couple celebrating success while looking at smartphone.
Broker Notes

Bell Potter names the best ASX shares to buy in April

What is the broker recommending to clients this month? Let's find out.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Market News

3 exciting ASX ETFs for growth investors

Looking for growth options? Here are three funds to consider buying.

Read more »

A man looking at his laptop and thinking.
Share Market News

5 things to watch on the ASX 200 on Tuesday

Here's what to expect on the ASX 200 after the Easter break.

Read more »

green arrow rising from within a trolley.
Defensive Shares

Woolworths' $37 share price is near an all-time high, so why am I going to buy some as soon as possible?

Why I still see Woolworths shares as a buy despite trading near all-time highs.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Broker Notes

Buy, hold, sell: Aristocrat, BHP, and Woodside shares 

Analysts have given their verdict on these shares. What are they saying?

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Broker Notes

Buy, hold, sell: Cochlear, South32, and Westpac shares

Analysts have given their verdict on these popular shares.

Read more »

Woman with a scared look has hands on her face.
Share Market News

These are the 10 most shorted ASX shares

Let's see which shares short sellers are targeting this week.

Read more »